BioGaia AB
(OTC: BIOGY)
|
7:51 PM UTC, 06/28/24 | |||
---|---|---|---|---|
Last: $11.50 | Change: -0.58 | %Change: -4.80% | Volume: 750 |
Open: | $ 11.50 | Volume: | 750 | |
---|---|---|---|---|
High: | $ 11.50 | Yield(%) | 4.16 | |
Low: | $ 11.50 | P/E Ratio (ttm): | 33.51 | |
Dividend ($): | 0.48 | Market Cap ($): | 2.26B | |
EPS ($) | 0.35 | Shares Out: | 194.56M |
% Price Change (last 4 weeks): | -3.37 |
---|---|
% Price Change (last 13 weeks): | -0.12 |
% Price Change (last 26 weeks): | 15.71 |
% Price Change (last 52 weeks): | 8.08 |
% Price Change (year to date): | 15.81 |
Return on Equity (%): | 17.61 |
---|---|
Return on Assets (%): | 15.50 |
Return on Invested Capital (%): | 19.47 |
Gross Profit Margin (%): | 72.81 |
---|---|
Net Profit Margin (%): | 28.18 |
Operating Profit Margin (%): | 33.81 |
|
|
50-day Moving Average: | $n/a |
---|---|
200-day Moving Average: | $n/a |
Avg. Daily Vol. (last 50 days): | n/a |
Avg. Daily Vol. (last 200 days): | n/a |
52-wk high: | $12.09 |
52-wk low: | $8.75 |
Bid: | $n/a |
Ask: | $n/a |
BioGaia AB engages in the development, marketing, and sale of probiotic products. It operates through the following segments: Pediatrics, Adult Health, and Other. The Pediatrics segment sells drops, oral rehydration solutions, digestive health tablets, and also royalties pertaining to pediatric products. The Adult Health segment include gut health tablets, oral health products, and offers cultures as an ingredient in a licensee's dairy product. The Other segment consists royalties from the development projects, and revenue from packaging solutions. The company was founded by Jan Annwall and Peter Michael Rothschild in 1990 and is headquartered in Stockholm, Sweden.
|
BioGaia AB
Kungsbroplan 3 Stockholm AB 112 27 Phone: 46.8.555.293.00 Fax: 46.8.555.293.01 http://www.biogaia.com |
Earnings (1year) ($): | n/a |
---|---|
Annual Dividend ($): | 0.48 |
Current P/E Ratio (ttm): | 33.51 |
Book Value ($): | 2.00 |
Cash Flow ($): | 0.38 |
Price/Earnings (x): | 33.51 |
---|---|
Price/Sales (x): | 8.30 |
Price/Book (x): | 5.03 |
Price/Cash Flow (x): | 25.27 |
Quick Ratio (x): | 8.65 |
---|---|
Current Ratio (x): | 9.58 |
LT Debt/Equity (x): | 0.00 |
Total Debt/Equity (x): | 0.43 |